Neoscreen 17OHP
Early Detection, Accurate Monitoring A precise fluorometric enzyme immunoassay for quantifying 17-hydroxyprogesterone in dried blood spot ...

Overview
Protective apparel requires proper storage to maintain hygiene and extend shelf life. The Mobile Storage System with Hangers provides a compact, mobile solution for organizing multiple pairs of apparel and accessories efficiently. Easy to install and move, it maximizes space without compromising safety.
Clinical Relevance
Congenital Adrenal Hyperplasia (CAH) is a group of disorders characterized by insufficient cortisol production. Cortisol regulates blood sugar, electrolytes, body fluids, and stress response. Early diagnosis is critical, as CAH cannot be cured but can be managed effectively with steroid substitution therapy.

Key Features
- Quantitative measurement of 17-hydroxyprogesterone from dried blood spots
- Simple, competitive enzyme immunoassay format
- High sensitivity and specificity
- Minimal sample preparation required
- Reliable and reproducible results
- Supports early detection and ongoing treatment monitoring
Technical Specifications
- Sample Type : Dried blood spot (DBS)
- Assay Type : Fluorometric enzyme immunoassay (FEIA)
- Detection : Quantitative measurement of 17-hydroxyprogesterone
- Sample Volume : Minimal (optimized for newborn screening)
Benefits
- Enables early detection of CAH in newborns
- Supports precise dosing for steroid replacement therapy
- Facilitates monitoring of treatment effectiveness
- Reduces risk of complications through timely intervention
